New research provides an insight into why cervical cancer is less common in certain regions of the world even though they may have limited screening and fewer or no prevention programs. Though the preliminary findings, published early online in CANCER, a peer-reviewed journal of the American Cancer Society, don’t rule out a cultural explanation or other reasons, they explore how genetic factors may also help explain this trend.
New research provides an insight into why cervical cancer is less common in certain regions of the world even though they may have limited screening and fewer or no prevention programs. Though the preliminary findings, published early online in CANCER, a peer-reviewed journal of the American Cancer Society, don’t rule out a cultural explanation or other reasons, they explore how genetic factors may also help explain this trend.
Approximately eight out of 10 cervical cancer deaths worldwide occur in low- and middle-income countries, but a few geographical regions—such as Western Asia including Saudi Arabia—have low cervical cancer rates despite the lack of national screening or vaccination programs against human papillomavirus (HPV), which is transmitted sexually and is the main cause of cervical cancer.
Ghazi Alsbeih, MD, PhD, of the King Faisal Specialist Hospital & Research Centre in Saudi Arabia, and his colleagues collected tumor samples and demographic data from 232 patients treated for invasive cervical cancers and compared the information with 313 matched controls without cancer.
The researchers found that cervical cancer in their Saudi national cohort displayed two peaks of increased incidence at 43 and 61 years of age. “As cancer development takes years to decades, the first peak could be a consequence of early sexual encounters, which often occurs at the end of the teenage period to the early thirties, while the second rebound could correspond to new encounters later in life,” explained Dr. Alsbeih. “The latter is generally occasioned by separation, failure of a first marriage, or simply second marriages in polygamous societies, which brings in an added risk of HPV infections as the number of lifetime sexual partners increases.”
Worldwide, 85 percent to 99 percent of patients with cervical cancer are HPV-positive, but in this study, only 77 percent were.
Dr. Alsbeih and his colleagues looked to genetics to explore why cervical cancer rates may be lower in Saudi Arabia than in other regions such as the United States. They found that HPV-negative patients in this study were more likely to show a particular variant in the gene that encodes the p53 tumor suppressor protein: a cytosine (C) rather than a guanine (G) in the DNA code, which leads to the production of a proline rather than an arginine amino acid in the translated protein. The authors hypothesize that this C variant therefore could be associated with a reduced likelihood for HPV infection. Less HPV cervical infection is associated with less cervical cancer risk. Though the G allele is considered the majority allele, the C variant was more commonly observed in this cohort than it is in populations from other parts of the world that show higher incidences of cervical cancer.
The optimistic conclusion about a protective role for this genetic variant is provocative, but the authors acknowledge that differing cultural norms could also help explain the lower rates of cervical cancer in Saudi Arabia.
Infection with HPV is the most common sexually transmitted disease (STD) in the United States. April is STD Awareness Month.
The study was supported by the Kingdom of Saudi Arabia’s National Science, Technology, and Innovation Plan.
Additional Information
Full Citation: “Reduced Rate of HPV Infection and Genetic Over-Transmission of TP53 72C Polymorphic Variant Lower Cervical Cancer Incidence.” Ghazi A. Alsbeih, MD, Najla M. Al-Harbi, Sara S. Bin Judia, Hatim A. Khoja, Mohamed M. Shoukri, Asma M. Tulbah. CANCER; Published Online: April 10, 2017 (DOI: 10.1002/cncr.30635).
Link to Study: http://doi.wiley.com/10.1002/cncr.30635
Author Contact: Hamoud Alotaibi, of the Public & Media Affairs Office at the King Faisal Specialist Hospital & Research Centre, at HamoudOtaibi@kfshrc.edu.sa or +966-11-216 2919 extension 27588.
About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online at http://wileyonlinelibrary.com/journal/cancer.
About Wiley
Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at www.wiley.com.
Dawn Peters
(US) +1 781-388-8408
sciencenewsroom@wiley.com